antibody-drug conjugates: next-generation linker technology for ind submissions
Published 6 months ago • 135 plays • Length 0:53Download video MP4
Download video MP3
Similar videos
-
2:52
the next generation pharmaceuticals - antibody-drug conjugates (adcs)
-
30:15
manufacturing concepts for antibody-drug conjugates | webinar
-
1:44
what are antibody-drug conjugates and how do they work against cancer?
-
1:42
what are antibody drug conjugates (adcs)?
-
9:24
the development of a next generation antibody drug conjugate adc
-
38:07
antibody-drug conjugates (adcs): current research and overcoming challenges - webinar playback
-
2:06
linkers for adc from tci
-
0:58
how does it work? | antibody drug conjugates
-
27:03
antibody drug conjugates: the end of chemotherapy | 2023 west oncology conference
-
3:32
introducing next-generation antibodies
-
3:34
targeting tumours: challenges of antibody-drug conjugates
-
2:41
how do antibody-drug conjugates adcs work?
-
0:08
antibody drug conjugates/adcs (cerebro global)
-
3:33
what are antibody-drug conjugates (adcs)?
-
1:05:07
the latest in gynecologic cancers: the abcs of adcs (antibody-drug conjugates)
-
3:29
2nd generation adc technology
-
1:00
optimize your antibody drug conjugates with shielded linkers. create happy adc’s!
-
0:23
smartag™ antibody drug conjugate technology | why catalent?
-
10:21
novel antibody-drug conjugates (adcs) technologies for management of mbc